Massachusetts Financial Services’s Core Laboratories CLB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,905,532
| Closed | -$52.9M | – | 898 |
|
|
2021
Q3 | $52.9M | Sell |
1,905,532
-595,539
| -24% | -$18.1M | 0.02% | 489 |
|
|
2021
Q2 | $97.4M | Sell |
2,501,071
-468,258
| -16% | -$16.8M | 0.03% | 406 |
|
|
2021
Q1 | $85.5M | Sell |
2,969,329
-15,991
| -0.5% | -$546K | 0.03% | 406 |
|
|
2020
Q4 | $79.1M | Sell |
2,985,320
-302,072
| -9% | -$6.17M | 0.03% | 401 |
|
|
2020
Q3 | $50.2M | Sell |
3,287,392
-20,747
| -0.6% | -$435K | 0.02% | 430 |
|
|
2020
Q2 | $67.2M | Sell |
3,308,139
-37,313
| -1% | -$669K | 0.03% | 378 |
|
|
2020
Q1 | $34.6M | Sell |
3,345,452
-1,410,354
| -30% | -$39.4M | 0.02% | 428 |
|
|
2019
Q4 | $179M | Buy |
4,755,806
+36,982
| +0.8% | +$1.66M | 0.07% | 227 |
|
|
2019
Q3 | $220M | Buy |
4,718,824
+482,459
| +11% | +$22.4M | 0.09% | 192 |
|
|
2019
Q2 | $221M | Buy |
4,236,365
+1,040,991
| +33% | +$61.1M | 0.09% | 189 |
|
|
2019
Q1 | $220M | Buy |
3,195,374
+586,476
| +22% | +$39.3M | 0.09% | 189 |
|
|
2018
Q4 | $156M | Buy |
2,608,898
+711,739
| +38% | +$61.4M | 0.07% | 210 |
|
|
2018
Q3 | $220M | Buy |
1,897,159
+149,762
| +9% | +$16.9M | 0.09% | 197 |
|
|
2018
Q2 | $221M | Sell |
1,747,397
-39,854
| -2% | -$4.85M | 0.09% | 188 |
|
|
2018
Q1 | $193M | Buy |
1,787,251
+351,847
| +25% | +$38.9M | 0.08% | 209 |
|
|
2017
Q4 | $157M | Buy |
1,435,404
+49
| +0% | +$4.89K | 0.07% | 221 |
|
|
2017
Q3 | $142M | Buy |
1,435,355
+6,931
| +0.5% | +$672K | 0.06% | 229 |
|
|
2017
Q2 | $145M | Buy |
1,428,424
+500,057
| +54% | +$53.9M | 0.06% | 222 |
|
|
2017
Q1 | $107M | Sell |
928,367
-1,941
| -0.2% | -$226K | 0.05% | 249 |
|
|
2016
Q4 | $112M | Buy |
930,308
+12,995
| +1% | +$1.44M | 0.05% | 241 |
|
|
2016
Q3 | $103M | Buy |
917,313
+161,597
| +21% | +$18.6M | 0.05% | 253 |
|
|
2016
Q2 | $93.6M | Buy |
755,716
+2,875
| +0.4% | +$347K | 0.05% | 254 |
|
|
2016
Q1 | $84.6M | Buy |
752,841
+161,433
| +27% | +$16.8M | 0.04% | 265 |
|
|
2015
Q4 | $64.3M | Buy |
+591,408
| New | +$67.7M | 0.03% | 304 |
|
|
2015
Q3 | – | Sell |
-55,702
| Closed | -$6.35M | – | 868 |
|
|
2015
Q2 | $6.35M | Sell |
55,702
-12,438
| -18% | -$1.51M | ﹤0.01% | 650 |
|
|
2015
Q1 | $7.12M | Sell |
68,140
-573
| -0.8% | -$61K | ﹤0.01% | 640 |
|
|
2014
Q4 | $8.27M | Sell |
68,713
-11,497
| -14% | -$1.51M | ﹤0.01% | 633 |
|
|
2014
Q3 | $11.7M | Sell |
80,210
-5,246
| -6% | -$810K | 0.01% | 617 |
|
|
2014
Q2 | $14.3M | Buy |
85,456
+7,577
| +10% | +$1.35M | 0.01% | 584 |
|
|
2014
Q1 | $15.5M | Sell |
77,879
-8,304
| -10% | -$1.57M | 0.01% | 537 |
|
|
2013
Q4 | $16.5M | Buy |
86,183
+7,769
| +10% | +$1.45M | 0.01% | 496 |
|
|
2013
Q3 | $13.3M | Buy |
78,414
+1,646
| +2% | +$255K | 0.01% | 522 |
|
|
2013
Q2 | $11.6M | Buy |
+76,768
| New | +$10.9M | 0.01% | 518 |
|
Other funds holding CLB
AI
FAM
DGI
Massachusetts Financial Services's CLB Position: Q4 2021 in Review
Massachusetts Financial Services sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 1,905,532 shares — an estimated $52.9M sold.
Massachusetts Financial Services first reported a position in CLB in Q2 2013 and held it in 33 quarters. The position peaked at $221M in Q2 2019. 174 funds tracked by Wall St. Rank hold CLB as of Q4 2021.
- Massachusetts Financial Services reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
- Massachusetts Financial Services sold 1,905,532 Core Laboratories shares in Q4 2021, an estimated $52.9M.
- Massachusetts Financial Services first reported a position in Core Laboratories in Q2 2013 and held it in 33 quarters.
- Massachusetts Financial Services's Core Laboratories position peaked at $221M in Q2 2019.
- 174 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.
Based on Massachusetts Financial Services's 13F filing for Q4 2021, filed 10 Feb 2022.